Breast–Ovarian Hereditary Cancer Syndrome: Beyond BRCA1 and BRCA2
Evgeny Imyanitov, Anna Sokolenko · 2026
Read Breast–Ovarian Hereditary Cancer Syndrome: Beyond BRCA1 and BRCA2 by Evgeny Imyanitov, Anna Sokolenko (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13605284.txt.
Description
Evgeny Imyanitov and Anna Sokolenko review inherited breast and ovarian cancer genes beyond the famous pair in a 2026 paper. BRCA1 and BRCA2 anchor genetic testing, but other genes carry proven or likely risk. Knowing which ones matter guides both screening and drug choice.
PALB2 raises breast cancer risk strongly, while three other genes lean toward ovarian cancer. Some findings steer therapy: several gene faults make tumors sensitive to PARP-blocking drugs, and one points toward AKT-lowering drugs. Other listed genes only double risk or less. Rare double faults can cause severe disease needing intensive care. The authors expect wide gene panels to dominate testing, which makes careful reading of results ever more important.
Catalog record
| CREATOR | Evgeny Imyanitov, Anna Sokolenko |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 26 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |